These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 8503923)
21. [Experimental therapy: reactivation of the FMR1 gene involved in fragile X syndrome]. Chiurazzi P; Neri G Rev Neurol; 2001 Oct; 33 Suppl 1():S62-5. PubMed ID: 12447822 [TBL] [Abstract][Full Text] [Related]
22. Mosaicism in a fragile X male including a de novo deletion in the FMR1 gene. Petek E; Kroisel PM; Schuster M; Zierler H; Wagner K Am J Med Genet; 1999 May; 84(3):229-32. PubMed ID: 10331598 [TBL] [Abstract][Full Text] [Related]
23. Promoter hypermethylation-mediated inactivation of LRRC4 in gliomas. Zhang Z; Li D; Wu M; Xiang B; Wang L; Zhou M; Chen P; Li X; Shen S; Li G BMC Mol Biol; 2008 Nov; 9():99. PubMed ID: 18976507 [TBL] [Abstract][Full Text] [Related]
24. Monozygotic twin brothers with the fragile X syndrome: different CGG repeats and different mental capacities. Helderman-van den Enden AT; Maaswinkel-Mooij PD; Hoogendoorn E; Willemsen R; Maat-Kievit JA; Losekoot M; Oostra BA J Med Genet; 1999 Mar; 36(3):253-7. PubMed ID: 10204857 [TBL] [Abstract][Full Text] [Related]
25. Acute lymphoblastic leukemia in a patient with fragile X syndrome: cytogenetic and molecular features. Au WY; Man C; Pang A; Kwong YL Haematologica; 2003 Apr; 88(4):ECR13. PubMed ID: 12681986 [TBL] [Abstract][Full Text] [Related]
26. [Analysis of expression of FMR-1 gene in male patients with fragile X syndrome using RT-PCR]. Zhu W; Li M; Zhao Y Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Feb; 15(1):17-9. PubMed ID: 9456366 [TBL] [Abstract][Full Text] [Related]
27. Preimplantation diagnosis for fragile X syndrome based on the detection of the non-expanded paternal and maternal CGG. Sermon K; Seneca S; Vanderfaeillie A; Lissens W; Joris H; Vandervorst M; Van Steirteghem A; Liebaers I Prenat Diagn; 1999 Dec; 19(13):1223-30. PubMed ID: 10660959 [TBL] [Abstract][Full Text] [Related]
28. Cloning, characterization and properties of plasmids containing CGG triplet repeats from the FMR-1 gene. Shimizu M; Gellibolian R; Oostra BA; Wells RD J Mol Biol; 1996 May; 258(4):614-26. PubMed ID: 8636996 [TBL] [Abstract][Full Text] [Related]
29. Methylation analysis of CGG sites in the CpG island of the human FMR1 gene. Hansen RS; Gartler SM; Scott CR; Chen SH; Laird CD Hum Mol Genet; 1992 Nov; 1(8):571-8. PubMed ID: 1301165 [TBL] [Abstract][Full Text] [Related]
30. CpG methylation-dependent repression of the human O6-methylguanine-DNA methyltransferase gene linked to chromatin structure alteration. Bhakat KK; Mitra S Carcinogenesis; 2003 Aug; 24(8):1337-45. PubMed ID: 12807730 [TBL] [Abstract][Full Text] [Related]
31. Fragile X DNA triplet repeats, (GCC)n, form hairpins with single hydrogen-bonded cytosine.cytosine mispairs at the CpG sites: isotope-edited nuclear magnetic resonance spectroscopy on (GCC)n with selective 15N4-labeled cytosine bases. Mariappan SV; Silks LA; Bradbury EM; Gupta G J Mol Biol; 1998; 283(1):111-20. PubMed ID: 9761677 [TBL] [Abstract][Full Text] [Related]
32. The fragile X phenotype in a mosaic male with a deletion showing expression of the FMR1 protein in 28% of the cells. de Graaff E; de Vries BB; Willemsen R; van Hemel JO; Mohkamsing S; Oostra BA; van den Ouweland AM Am J Med Genet; 1996 Aug; 64(2):302-8. PubMed ID: 8844070 [TBL] [Abstract][Full Text] [Related]
33. [Direct molecular analysis of FMR-1 gene mutation in patients with fragile Xq syndrome and their families]. Alliende MA; Urzúa B; Valiente A; Cortés F; Curotto B; Rojas C Rev Med Chil; 1998 Dec; 126(12):1435-46. PubMed ID: 10349157 [TBL] [Abstract][Full Text] [Related]
34. [Detection of hypermethylation in affected males with fragile X syndrome by PCR assay]. Chai J; Shen Y; Fan Y; Zhao S; Wu G Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Feb; 17(1):47-51. PubMed ID: 7781128 [TBL] [Abstract][Full Text] [Related]
35. Redistribution of transcription start sites within the FMR1 promoter region with expansion of the downstream CGG-repeat element. Beilina A; Tassone F; Schwartz PH; Sahota P; Hagerman PJ Hum Mol Genet; 2004 Mar; 13(5):543-9. PubMed ID: 14722156 [TBL] [Abstract][Full Text] [Related]
36. Timing of the absence of FMR1 expression in full mutation chorionic villi. Willemsen R; Bontekoe CJ; Severijnen LA; Oostra BA Hum Genet; 2002 Jun; 110(6):601-5. PubMed ID: 12107447 [TBL] [Abstract][Full Text] [Related]
37. Effect of in vitro promoter methylation and CGG repeat expansion on FMR-1 expression. Sandberg G; Schalling M Nucleic Acids Res; 1997 Jul; 25(14):2883-7. PubMed ID: 9207038 [TBL] [Abstract][Full Text] [Related]
38. Epigenetic variation illustrated by DNA methylation patterns of the fragile-X gene FMR1. Stöger R; Kajimura TM; Brown WT; Laird CD Hum Mol Genet; 1997 Oct; 6(11):1791-801. PubMed ID: 9302255 [TBL] [Abstract][Full Text] [Related]
39. Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain. Abitbol M; Menini C; Delezoide AL; Rhyner T; Vekemans M; Mallet J Nat Genet; 1993 Jun; 4(2):147-53. PubMed ID: 8348153 [TBL] [Abstract][Full Text] [Related]
40. Reduced cyclic AMP production in fragile X syndrome: cytogenetic and molecular correlations. Berry-Kravis E; Hicar M; Ciurlionis R Pediatr Res; 1995 Nov; 38(5):638-43. PubMed ID: 8552427 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]